Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines

Cancer Letters - Tập 119 - Trang 63-70 - 1997
M. Abu-hadid1, J.D. Wilkes1, Z. Elakawi1, L. Pendyala1, R.P. Perez1
1Departments of Solid Tumor Oncology and Investigational Therapeutics, Division of Medicine, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA

Tài liệu tham khảo

Ozols, 1992, Epithelial ovarian cancer, 731 Sutton, 1989, Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma, J. Clin. Oncol., 7, 223, 10.1200/JCO.1989.7.2.223 Andrews, 1990, Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance, Cancer Cells, 2, 35 Perez, 1990, Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems, Pharmacol. Ther., 48, 19, 10.1016/0163-7258(90)90015-T Perez, 1991, Ovarian cancer biology, 18, 186 Kelland, 1994, The molecular basis of cisplatin sensitivity/resistance, Eur. J. Cancer, 30A, 725, 10.1016/0959-8049(94)90281-X Hartl, 1994, Molecular chaperones in protein folding: the art of avoiding sticky situations, Trends Biochem. Sci., 19, 20, 10.1016/0968-0004(94)90169-4 Craig, 1993, Heat shock proteins: molecular chaperones of protein biogenesis, Microbiol. Rev., 57, 402, 10.1128/MR.57.2.402-414.1993 Welch, 1991, The role of heat-shock proteins as molecular chaperones, Curr. Opin. Cell Biol., 3, 1033, 10.1016/0955-0674(91)90125-I Ellis, 1991, Molecular chaperones, Annu. Rev. Biochem., 60, 321, 10.1146/annurev.bi.60.070191.001541 Martin, 1992, Prevention of protein denaturation under heat stress by the chaperonin Hsp60, Science, 258, 995, 10.1126/science.1359644 Enns, 1991, An amplified mitochondrial chaperonin gene causes resistance to cisplatin in human ovarian tumor cells (abstract), 32, 353 Kimura, 1993, Correlation of me survival of ovarian cancer patients with mRNA expression of the 60-kD heat shock protein HSP-60, J. Clin. Oncol., 11, 891, 10.1200/JCO.1993.11.5.891 Nakata, 1994, Association between overexpression of hsp60 and cisplatin resistance in head and neck cancer cells (abstract), 35, 466 Shen, 1994, A 52 kD protein is overexpressed in cisplatin-resistant human liver carcinoma cells and in cisplatin-resistant mouse cells after DNA-mediated transformation (abstract), 35, 441 Shen, 1995, Identification of a protein overexpressed in cisplatin-resistant cell lines derived from human liver carcinoma and mouse Balb/3T3 cells as the heat shock protein HSP60 (abstract), 36, 401 Misset, 1991, Oxaliplatin (1-OHP): experimental and clinical studies, 369 Cvitkovic, 1994, High activity in pretreated germ cell tumors (GCT) of combined oxaliplatin (1-OHP) cisplatin (CP) based salvage regimen (abstract), 35, 233 Misset, 1994, High efficacy of combined oxaliplatin (1-OHP) cisplatin (CP) as salvage treatment in pretreated ovarian cancer (OC) (abstract), 35, 234 Behrens, 1987, Characterization of a cis-diamminedichloroplatinum (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues, Cancer Res., 47, 414 Godwin, 1992, High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis, 89, 3070 Masuda, 1988, Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines, Cancer Res., 48, 5713 Johnson, 1994, Role of platinum-DNA adduct formation and removal in cisplatin resistance in human ovarian cancer cell lines, Biochem. Pharmacol., 47, 689, 10.1016/0006-2952(94)90132-5 Glavy, 1994, Isolation and preliminary characterization of oxaliplatin resistant A2780 ovarian carcinoma sublines (abstract), 35, 434 Russell, 1986, Bladder cancer xenografts: a model of tumor cell heterogeneity, Cancer Res., 46, 2035 Skehan, 1990, New colorimetric cytotoxicity assay for anticancer drug screening, J. Natl. Cancer Inst., 82, 1107, 10.1093/jnci/82.13.1107 Perez, 1993, A comparison of clonogenic, microtetrazolium (MTT), and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines, Eur. J. Cancer, 29A, 395, 10.1016/0959-8049(93)90394-U Chomczynski, 1993, A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples, Biotechniques, 15, 532 Warren, 1991, Rapid analysis and quantitation of PCR products by high-performance liquid chromatography, Biotechniques, 11, 250 El-akawi, 1996, Altered glutathione metabolism in oxaliplatin resistant ovarian carcinoma cells, Cancer Lett., 105, 5, 10.1016/0304-3835(96)04245-0 Venner, 1990, Nucleotide sequences and novel structural features of human and Chinese hamster hsp60 (chaperonin) gene families, DNA Cell Biol., 9, 545, 10.1089/dna.1990.9.545 Richards, 1996, Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells, Cancer Res., 56, 2446